Nurse Practitioners and PAs: Who Can Prescribe GLP-1s in Your State

The NP and PA Prescribing Landscape

Nurse practitioners (NPs) and physician assistants (PAs) are responsible for a growing share of GLP-1 prescriptions, particularly in telehealth. Understanding their prescribing authority in your state helps you evaluate whether your prescriber is operating within their legal scope — and whether an NP or PA may actually be a better fit for your GLP-1 care than waiting months for a specialist physician appointment.

The key variable is state law. NP prescribing authority falls into three categories: full practice authority (the NP can diagnose, treat, and prescribe independently), reduced practice (requires a collaborative agreement with a physician but can still prescribe), and restricted practice (requires direct supervision by a physician). PAs generally practice under a similar framework with supervisory requirements that vary by state.

Full Practice Authority States

In states with full practice authority, NPs can prescribe GLP-1 medications independently — no physician oversight required. These states recognize NPs as independent providers who can evaluate patients, order labs, diagnose conditions, and prescribe controlled and non-controlled substances. As of 2026, over 25 states and the District of Columbia grant full practice authority to NPs.

For GLP-1 patients in full practice authority states, this means more access points: NPs can prescribe on telehealth platforms, in primary care clinics, in urgent care settings, and in specialty weight management practices. The practical effect is shorter wait times and broader geographic access, particularly in rural areas where physician availability is limited.

What This Means for Your Prescription's Validity

An NP- or PA-written GLP-1 prescription is clinically and legally identical to a physician-written prescription — assuming the prescriber is operating within their state's scope of practice. Pharmacies fill them the same way. Insurance processes them the same way. Prior authorizations use the same criteria regardless of prescriber type.

One nuance: some insurance plans require prior authorizations to be initiated by a physician (MD or DO) rather than an NP or PA. This is increasingly rare but still exists in some plans. If your PA-written PA (prior authorization from a PA — yes, the acronym overlap is unfortunate) is denied, ask whether the issue is clinical criteria or prescriber type.

NPs and PAs on Telehealth Platforms

Many GLP-1 telehealth platforms staff primarily with NPs and PAs rather than physicians. This is legal and appropriate in states where these providers have prescribing authority. The clinical evaluation should be no different — the same intake questions, the same safety screening, the same prescribing criteria apply regardless of the provider's credential type.

What to look for: your prescriber's credentials should be visible on the platform — their name, license type (NP, PA, MD, DO), and state of licensure. If a platform doesn't identify your prescriber by name and credential, that's a transparency gap worth questioning. You have the right to know who is writing your prescription.